StockNews.AI
AVTR
Benzinga
12 days

Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure

1. AVTR's Q2 2025 EPS was 24 cents, below expectations of 25 cents. 2. Sales reached $1.68 billion, slightly matching consensus but down 1% year-over-year. 3. Net income fell to $64.7 million, down from $92.9 million last year. 4. Laboratory Solutions sales decreased by 3%, with organic sales down 1%. 5. Goldman Sachs downgraded AVTR amid a significant 60% decline since 2021.

5m saved
Insight
Article

FAQ

Why Bearish?

AVTR's earnings miss, declining sales, and reduced net income signal ongoing struggles, reminiscent of past downturns.

How important is it?

The article reports financial performance and a downgrade, crucial for AVTR investor sentiment.

Why Short Term?

Immediate market reactions driven by earnings surprises typically influence stock prices in the short term.

Related Companies

Related News